Baltimore Convention CenterBaltimore, MD
Disclosure Statement
Having an interest in or affiliation with any corporate organization does not prevent a speaker from making a presentation, but the relationship must be made known to the audience in advance to be in compliance with the Accreditation Council for Continuing Medical Education (ACCME).
In accordance with ACCME guidelines, we want to ensure balance, independence, objectivity and scientific rigor at all accredited programs. The Society of Cardiovascular Anesthesiologists requires that all faculty make full disclosure. Full disclosure entails indicating whether the faculty member named above and/or his/her immediate family has any relationships with pharmaceutical companies, biomedical device manufacturers and/or other corporations whose products or services are related to pertinent therapeutic areas. All faculty participating in SCA sponsored programs must agree to:
A) Disclose relationship with companies who manufacture products used in the treatment of the subjects under discussion. B) Disclose relationship between the speaker and commercial support of the activity. C) Use generic names of products, or several trade names D) Disclose any unlabeled uses of a commercial product, or an investigational use of a product not yet FDA approved.
All information disclosed will be printed in the program syllabus. If we do not receive your Disclosure Statement by the due date, we will note this in the syllabus and you will be required to disclose verbally on site prior to your lecture. Failure to comply with the disclosure policy will preclude participation in the CME program.
A) Relationship with companies who manufacture products used in the treatment of the subjects under discussion: Yes No If yes, list company(ies) with the relationship below.
B) Relationships with any of the commercial supporters of this CME activity: Yes No If yes, list company(ies) with the relationship below.
C) Generic and Trade Names Presentations must give a balanced view of therapeutic options. Presenters' use of general names will contribute to this impartiality. If trade names are used, those of several companies should be used rather than only that of a single supporting company
D) Unlabeled Uses of Products When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during an educational activity, the presenter is required to disclose that the product is not labeled for the use under discussion or that the product is still investigational.
Discussion of unlabeled uses: Yes No If yes, you must disclose this information during your presentation.
